Brazil's Pharma Agency To Adopt FDA Standards.

Chemical Market Reporter, March, 1999

To REDUCE the production of counterfeit pharmaceuticals, the Brazilian sanitary controls agency within the ministry of health is moving toward the adoption of US Food and Drug Administration market control standards, says Sylvio di Girolamo, executive director of the Brazilian Health Products Industry Association, according to a report by Gazeta Mercantil.

Estimates of counterfeit drugs run as high as 5 percent of the industry's annual sales of nearly RI 10 billion, about $5 billion. One reason the counterfeit market has emerged in Brazil is that many pharmaceuticals that require prescriptions in the US are sold over-the-counter in Brazil. Gazeta cites research by Bristol-Myers Squibb Brasil which estimates that OTC drug sales amount to about one-third of...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.